Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc (BIO) Covered Calls
As of September 25, 2026, BIO has 55 covered call opportunities in the coming three months. Return ranges from 3.1 to 47.5% until expiration. Annualized return ranges from 20.5 to 360.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $18,100.
Read more
Running BIO covered calls helps you generate consistent income from Bio-Rad Laboratories Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Bio-Rad Laboratories Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BIO covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BIO stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BIO covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Bio-Rad Laboratories Inc covered call is worth writing.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety.
This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Income-focused investors, long-term BIO holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BIO covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Bio-Rad Laboratories Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile69.25% Elevated
- Market cap (M$)10,235
- 52 weeks high-3.84%
- 52 weeks low60.94%
- Analyst recommendationHold
3.00 - Target price$341.25
-10.43% below the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-04
- P/E46.16
- Future P/E36.82
- EPS (ttm)8.25
- EPS growth next 5 years4.23%
As of September 25, 2026
| 2026-10-16 | 21 | 460.00 | 20.73 | 0.10 | 3.40 | 7910.00 | 20.76 | 360.85 | -0.03 | +0.08 | 0 | 3.30 |
| 2026-10-16 | 21 | 440.00 | 15.49 | 0.10 | 10.00 | 5910.00 | 15.51 | 269.61 | -0.03 | +0.18 | 0 | 9.90 |
| 2026-10-16 | 21 | 420.00 | 10.24 | 0.10 | 10.00 | 3910.00 | 10.26 | 178.37 | -0.03 | +0.22 | 1 | 9.90 |
| 2026-11-20 | 56 | 480.00 | 25.98 | 0.10 | 10.00 | 9910.00 | 26.01 | 169.53 | -0.03 | +0.14 | 0 | 9.90 |
| 2026-11-20 | 56 | 470.00 | 23.36 | 0.10 | 10.00 | 8910.00 | 23.39 | 152.43 | -0.03 | +0.15 | 0 | 9.90 |
| 2026-11-20 | 56 | 460.00 | 20.73 | 0.10 | 10.00 | 7910.00 | 20.76 | 135.32 | -0.03 | +0.16 | 0 | 9.90 |
| 2026-10-16 | 21 | 410.00 | 7.61 | 0.10 | 10.00 | 2910.00 | 7.64 | 132.75 | -0.03 | +0.24 | 1 | 9.90 |
| 2026-12-18 | 84 | 490.00 | 28.61 | 0.10 | 10.00 | 10910.00 | 28.64 | 124.43 | -0.03 | +0.14 | 0 | 9.90 |
| 2026-11-20 | 56 | 450.00 | 18.11 | 0.10 | 10.00 | 6910.00 | 18.14 | 118.21 | -0.03 | +0.17 | 0 | 9.90 |
| 2026-11-20 | 56 | 440.00 | 15.49 | 1.50 | 11.00 | 6050.00 | 15.88 | 103.50 | -0.39 | +0.20 | 0 | 9.50 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best BIO covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→